SEC 13F Intelligence

Alta Fundamental Advisers LLC / MIST

Alta Fundamental Advisers LLC’s Milestone Pharmaceuticals In Position

Does Alta Fundamental Advisers LLC own Milestone Pharmaceuticals In (MIST)? Not currently — the last reported position was 1.40M shares worth $3M in Q2 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$3M
Q2 2025
Shares
1.40M
% of Portfolio
+1.39%
Quarters Held
11
position exited

Position History MIST

Reported value by quarter
Q4 ’22: $2MQ4 ’22Q1 ’23: $4MQ2 ’23: $3MQ2 ’23Q3 ’23: $4MQ4 ’23: $3MQ4 ’23Q1 ’24: $4MQ2 ’24: $4MQ2 ’24Q3 ’24: $4MQ4 ’24: $6MQ4 ’24Q1 ’25: $1MQ2 ’25: $3MQ2 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q2 20251.40M$3M+1.39%
Q1 20251.43M$1M+0.73%
Q4 20242.66M$6M+1.88%
Q3 20242.66M$4M+1.16%
Q2 20242.66M$4M+1.11%
Q1 20242.37M$4M+1.61%
Q4 20231.67M$3M+1.26%
Q3 20231.18M$4M+1.74%
Q2 2023898.0K$3M+1.25%
Q1 2023898.0K$4M+1.50%
Q4 2022565.5K$2M+0.97%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Alta Fundamental Advisers LLC’s full portfolio or all institutional holders of MIST.